BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

390 related articles for article (PubMed ID: 33347989)

  • 1. Different mutations in SARS-CoV-2 associate with severe and mild outcome.
    Nagy Á; Pongor S; Győrffy B
    Int J Antimicrob Agents; 2021 Feb; 57(2):106272. PubMed ID: 33347989
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Global analysis of more than 50,000 SARS-CoV-2 genomes reveals epistasis between eight viral genes.
    Zeng HL; Dichio V; Rodríguez Horta E; Thorell K; Aurell E
    Proc Natl Acad Sci U S A; 2020 Dec; 117(49):31519-31526. PubMed ID: 33203681
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of SARS-CoV-2 Genomes from West Java, Indonesia.
    Fibriani A; Stephanie R; Alfiantie AA; Siregar ALF; Pradani GAP; Yamahoki N; Purba WS; Alamanda CNC; Rahmawati E; Rachman RW; Robiani R; Ristandi RB
    Viruses; 2021 Oct; 13(10):. PubMed ID: 34696527
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assessment of intercontinents mutation hotspots and conserved domains within SARS-CoV-2 genome.
    Omotoso OE; Olugbami JO; Gbadegesin MA
    Infect Genet Evol; 2021 Dec; 96():105097. PubMed ID: 34606987
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative insight into the genomic landscape of SARS-CoV-2 and identification of mutations associated with the origin of infection and diversity.
    Mishra D; Suri GS; Kaur G; Tiwari M
    J Med Virol; 2021 Apr; 93(4):2406-2419. PubMed ID: 33347622
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Introduction into the Marseille geographical area of a mild SARS-CoV-2 variant originating from sub-Saharan Africa: An investigational study.
    Colson P; Levasseur A; Gautret P; Fenollar F; Thuan Hoang V; Delerce J; Bitam I; Saile R; Maaloum M; Padane A; Bedotto M; Brechard L; Bossi V; Ben Khedher M; Chaudet H; Million M; Tissot-Dupont H; Lagier JC; Mboup S; Fournier PE; Raoult D
    Travel Med Infect Dis; 2021; 40():101980. PubMed ID: 33535105
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Proteo-Genomic Analysis of SARS-CoV-2: A Clinical Landscape of Single-Nucleotide Polymorphisms, COVID-19 Proteome, and Host Responses.
    Tushir S; Kamanna S; Nath SS; Bhat A; Rose S; Aithal AR; Tatu U
    J Proteome Res; 2021 Mar; 20(3):1591-1601. PubMed ID: 33555895
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Global variation in SARS-CoV-2 proteome and its implication in pre-lockdown emergence and dissemination of 5 dominant SARS-CoV-2 clades.
    Patro LPP; Sathyaseelan C; Uttamrao PP; Rathinavelan T
    Infect Genet Evol; 2021 Sep; 93():104973. PubMed ID: 34147651
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential mutation profile of SARS-CoV-2 proteins across deceased and asymptomatic patients.
    Laskar R; Ali S
    Chem Biol Interact; 2021 Sep; 347():109598. PubMed ID: 34303694
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quantitative Mutation Analysis of Genes and Proteins of Major SARS-CoV-2 Variants of Concern and Interest.
    Liang F
    Viruses; 2023 May; 15(5):. PubMed ID: 37243278
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Whole genome analysis of more than 10 000 SARS-CoV-2 virus unveils global genetic diversity and target region of NSP6.
    Saha I; Ghosh N; Pradhan A; Sharma N; Maity D; Mitra K
    Brief Bioinform; 2021 Mar; 22(2):1106-1121. PubMed ID: 33725111
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The importance of accessory protein variants in the pathogenicity of SARS-CoV-2.
    Hassan SS; Choudhury PP; Dayhoff GW; Aljabali AAA; Uhal BD; Lundstrom K; Rezaei N; Pizzol D; Adadi P; Lal A; Soares A; Mohamed Abd El-Aziz T; Brufsky AM; Azad GK; Sherchan SP; Baetas-da-Cruz W; Takayama K; Serrano-Aroca Ã; Chauhan G; Palu G; Mishra YK; Barh D; Santana Silva RJ; Andrade BS; Azevedo V; Góes-Neto A; Bazan NG; Redwan EM; Tambuwala M; Uversky VN
    Arch Biochem Biophys; 2022 Mar; 717():109124. PubMed ID: 35085577
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Longitudinal analysis of SARS-CoV-2 spike and RNA-dependent RNA polymerase protein sequences reveals the emergence and geographic distribution of diverse mutations.
    Showers WM; Leach SM; Kechris K; Strong M
    Infect Genet Evol; 2022 Jan; 97():105153. PubMed ID: 34801754
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genome sequencing of SARS-CoV-2 in a cohort of Egyptian patients revealed mutation hotspots that are related to clinical outcomes.
    Zekri AN; Mohanad M; Hafez MM; Soliman HK; Hassan ZK; Abouelhoda M; Amer KE; Seadawy MG; Ahmed OS
    Biochim Biophys Acta Mol Basis Dis; 2021 Aug; 1867(8):166154. PubMed ID: 33932525
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Temporal landscape of mutational frequencies in SARS-CoV-2 genomes of Bangladesh: possible implications from the ongoing outbreak in Bangladesh.
    Saha O; Islam I; Shatadru RN; Rakhi NN; Hossain MS; Rahaman MM
    Virus Genes; 2021 Oct; 57(5):413-425. PubMed ID: 34251592
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Generalized linear models provide a measure of virulence for specific mutations in SARS-CoV-2 strains.
    Oulas A; Zanti M; Tomazou M; Zachariou M; Minadakis G; Bourdakou MM; Pavlidis P; Spyrou GM
    PLoS One; 2021; 16(1):e0238665. PubMed ID: 33497392
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nucleocapsid (N) Gene Mutations of SARS-CoV-2 Can Affect Real-Time RT-PCR Diagnostic and Impact False-Negative Results.
    Lesbon JCC; Poleti MD; de Mattos Oliveira EC; Patané JSL; Clemente LG; Viala VL; Ribeiro G; Giovanetti M; de Alcantara LCJ; Teixeira O; Nonato MC; de Lima LPO; Martins AJ; Dos Santos Barros CR; Marqueze EC; de Souza Todão Bernardino J; Moretti DB; Brassaloti RA; de Lello Rocha Campos Cassano R; Mariani PDSC; Slavov SN; Dos Santos RB; Rodrigues ES; Santos EV; Borges JS; de La Roque DGL; Kitajima JP; Santos B; Assato PA; da Silva da Costa FA; Banho CA; Sacchetto L; Moraes MM; Palmieri M; da Silva FEV; Grotto RMT; Souza-Neto JA; Nogueira ML; Coutinho LL; Calado RT; Neto RM; Covas DT; Kashima S; Elias MC; Sampaio SC; Fukumasu H
    Viruses; 2021 Dec; 13(12):. PubMed ID: 34960743
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SARS-CoV-2 nucleocapsid and Nsp3 binding: an in silico study.
    Khan MT; Zeb MT; Ahsan H; Ahmed A; Ali A; Akhtar K; Malik SI; Cui Z; Ali S; Khan AS; Ahmad M; Wei DQ; Irfan M
    Arch Microbiol; 2021 Jan; 203(1):59-66. PubMed ID: 32749662
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pathogenic perspective of missense mutations of ORF3a protein of SARS-CoV-2.
    Hassan SS; Attrish D; Ghosh S; Choudhury PP; Roy B
    Virus Res; 2021 Jul; 300():198441. PubMed ID: 33940003
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structural Mapping of Mutations in Spike, RdRp and Orf3a Genes of SARS-CoV-2 in Influenza Like Illness (ILI) Patients.
    Alosaimi B; Naeem A; Alghoribi MF; Okdah L; Hamed ME; AlYami AS; Alotaibi A; Enani M
    Viruses; 2021 Jan; 13(1):. PubMed ID: 33477951
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.